The difference between domestically produced Bortezomib and imported

There is no fundamental difference in therapeutic efficacy and quality between domestically produced Bortezomib (Bortezomib) and imported Bortezomib because they both contain the same active ingredients and are produced according to the same international standards. However, there may be some minor differences and considerations:

1.Production standards and quality control: International pharmaceutical companies generally follow strict international quality standards and regulatory requirements to produce bortezomib to ensure the quality and safety of the drug. Domestic drugs must also comply with national or regional quality standards. The stringency of quality control procedures may vary between pharmaceutical companies and national regulations.

2.Price: Imported drugs are generally more expensive because they may include import fees, exchange rate risk, and other costs. Domestic drugs may be more competitive in price.

3.Drug Packaging and Labeling: Packaging and labeling of imported drugs are often based on international standards and may provide information in different languages. Domestic drugs are often labeled in local languages u200bu200band standards.

4.Supply availability: The supply availability of imported drugs may be affected by factors such as international logistics and the political stability of the manufacturing country. The supply of domestically produced drugs is generally more stable.

5.Patient preference: Patients and doctors may be more inclined to choose brands they are familiar with or trust, whether domestic or imported. This may be because of their trust in certain pharmaceutical companies or because of Medicare or drug plan requirements.

Bortezomib is already on the market in China and has been included in medical insurance. Patients can purchase it domestically at a price of around 3,000 to 4,000 yuan. Please consult the local hospital pharmacy for specific prices and reimbursement policies. The cheaper ones abroad are mainly Indian generic drugs, which cost around 1,000 yuan and have basically the same ingredients as the domestic bortezomib drug.